• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Senate panel once again slams physician-owned distributorships

Senate panel once again slams physician-owned distributorships

May 10, 2016 By Brad Perriello

Physician-owned distributorshipsThe U.S. Senate’s Finance Committee today issued a report slamming physician-owned distributorships that sell the spinal implants their doctor-owners prescribe.

It’s not the 1st time that so-called PODs have drawn scrutiny from federal officials. Back in 2011, a Senate Finance panel report prompted a group of senators to petition the U.S. Health & Human Services Dept.’s inspector general to investigate the businesses and warn that they may create incentives for doctors to give preference to devices that provide them a financial return. The finance committee’s 2011 report found that PODS existed in 20 states, with more than 40 in California alone.

In 2012 the HHS OIG issued a “Special Fraud Alert” labeling PODs as “inherently suspect” under Medicare’s anti-kickback rules. A 2013 OIG report found that the cost of spinal fusion surgeries rises when hospitals purchase medical devices from PODs, finding that 20% of the procedures used devices purchased from the doctor-owned distributors. The Justice Dept. joined the chorus that year, warning that the influence that doctors have over hospitals purchasing practices leaves room for serious conflicts of interest.

The Senate Finance report released today found that PODs had spread to 43 states and the District of Columbia as of November 2015. What’s more, the report found, surgeons at PODs saw 24% more patients than non-POD physicians and performed nearly twice the number of fusion procedures.

“Unchecked, this position of power can give POD spinal surgeons the opportunity to grant themselves a steady stream of income by increasing the use of the products supplied by their POD. PODs present an inherent conflict of interest that can put the physician’s medical judgment at odds with the patient’s best interests,” according to the report.

“The relationship between doctors their patients should be one characterized by trust and a level of professionalism that is held to the highest standards,” Finance chairman Sen. Orrin Hatch (R-Utah) said in prepared remarks. “Unfortunately, when surgeons have a financial interest in medical device companies, the data calls into question whether the best interest of the patient is considered when invasive surgeries are recommended. Patients are strongly inclined to follow their physician’s advice, and when doctors are able to recommend surgeries from which they financially benefit from the devices used, a clear conflict of interest is presented and the patients’ health can be put at risk.  Moreover, by recommending surgeries that may not be necessary, such arrangements can also inflate federal healthcare costs at the expense of taxpayers.  It is my hope that, with this report, we can continue to work towards expanding transparency and identifying how to better protect and inform patients about what could possibly be harmful POD arrangements.”

The Senate Finance report recommended tighter transparency laws requiring doctors to disclose their stakes in device companies to hospitals and patients. Hospitals should draft and enforce policies addressing PODs, with the Centers for Medicare & Medicaid Services setting a deadline for implementing POD policies and denying reimbursement for POD-supplied devices to hospitals without them.

“The business structure and payments associated with certain PODs have been found to be illegal. Furthermore, overt or implied threats made by physicians to move their practice unless a hospital accepts their POD would likely violate fraud and abuse laws,” according to the report. “Law enforcement should continue and expand their efforts to charge and prosecute those doctors, PODs, and hospitals that violate the law.”

Matthew Wetzel, assistant general counsel for AdvaMed, said the group was encouraged that the report distinguished between PODs and medical device companies that might have some physician ownership.

“AdvaMed has long raised concerns regarding PODs and has advocated for transparent, ethical business arrangements and ownership models for medical technology manufacturers and distributors under federal laws, consistent with the association’s code of ethics. We are committed to working with our members to continue to raise awareness and develop proactive advocacy solutions to address PODs-related concerns,” Wetzel said in an emailed statement.

Filed Under: Distribution Tagged With: Capitol Hill, Physician-owned distributors

More recent news

  • Ambu wins FDA clearance for first single-use cysto-nephroscope
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system
  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy